Stryker Income Statement Research

SYK Stock

USD 334.91 7.23 2.21%

Most accounts from Stryker's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Stryker current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Stryker Valuation and Stryker Correlation analysis.

For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.

At this time, Stryker's Operating Income is quite stable compared to the past year. EBIT is expected to rise to about 4.1 B this year, although the value of Non Operating Income Net Other will most likely fall to (149.3 M).

For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.At this time, Stryker's Operating Income is quite stable compared to the past year. EBIT is expected to rise to about 4.1 B this year, although the value of Non Operating Income Net Other will most likely fall to (149.3 M).

	2021	2022	2023	2024 (projected)
Gross Profit	11.0B	11.6B	13.1B	13.7B
Total Revenue	17.1B	18.4B	20.5B	21.5B

Gross Profit Total Revenue

Stryker income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling General Administrative	Research Development	Net Income From Continuing Ops	Non Recurring	Non Operating Income Net Other	Selling And Marketing Expenses	Minority Interest	Tax Provision	Interest Income	Reconciled Depreciation
Depreciation And Amortization		0.78	0.9	0.89	0.91	0.83	0.77	0.88	0.91	0.9	0.82	-0.25	0.72	0.11	0.86	0.93	0.6	0.56	-0.62	-0.34	-0.34	0.04	0.81	0.86
Interest Expense	0.78		0.77	0.76	0.78	0.73	0.65	0.72	0.8	0.76	0.71	-0.12	0.57	0.22	0.75	0.79	0.43	0.47	-0.47	-0.58	-0.58	0.18	0.73	0.86
Total Revenue	0.9	0.77		1.0	1.0	0.96	0.93	0.97	1.0	0.99	0.95	-0.39	0.83	0.14	0.99	0.98	0.6	0.75	-0.63	-0.59	-0.59	0.02	0.81	0.84
Gross Profit	0.89	0.76	1.0		1.0	0.96	0.93	0.97	0.99	0.99	0.95	-0.4	0.83	0.14	0.99	0.98	0.6	0.76	-0.63	-0.59	-0.59	0.01	0.8	0.82
Other Operating Expenses	0.91	0.78	1.0	1.0		0.94	0.9	0.95	1.0	1.0	0.93	-0.37	0.81	0.14	0.99	0.99	0.59	0.76	-0.63	-0.57	-0.57	0.02	0.82	0.85
Operating Income	0.83	0.73	0.96	0.96	0.94		0.99	0.99	0.95	0.93	1.0	-0.42	0.88	0.12	0.96	0.92	0.65	0.67	-0.55	-0.68	-0.68	0.0	0.75	0.76
Ebit	0.77	0.65	0.93	0.93	0.9	0.99		0.98	0.91	0.89	0.98	-0.53	0.85	0.15	0.92	0.88	0.61	0.67	-0.56	-0.65	-0.65	0.04	0.7	0.68
Ebitda	0.88	0.72	0.97	0.97	0.95	0.99	0.98		0.96	0.94	0.98	-0.48	0.85	0.14	0.95	0.93	0.64	0.67	-0.6	-0.59	-0.59	0.04	0.77	0.77
Cost Of Revenue	0.91	0.8	1.0	0.99	1.0	0.95	0.91	0.96		0.99	0.94	-0.37	0.82	0.14	0.98	0.99	0.6	0.74	-0.62	-0.6	-0.6	0.03	0.83	0.87
Total Operating Expenses	0.9	0.76	0.99	0.99	1.0	0.93	0.89	0.94	0.99		0.92	-0.37	0.8	0.14	0.99	0.98	0.57	0.78	-0.64	-0.55	-0.55	0.01	0.8	0.83
Income Before Tax	0.82	0.71	0.95	0.95	0.93	1.0	0.98	0.98	0.94	0.92		-0.37	0.89	0.12	0.95	0.9	0.65	0.64	-0.48	-0.7	-0.7	0.0	0.71	0.75
Total Other Income Expense Net	-0.25	-0.12	-0.39	-0.4	-0.37	-0.42	-0.53	-0.48	-0.37	-0.37	-0.37		-0.26	-0.18	-0.38	-0.35	-0.16	-0.56	0.76	0.05	0.05	-0.17	-0.46	-0.11
Net Income	0.72	0.57	0.83	0.83	0.81	0.88	0.85	0.85	0.82	0.8	0.89	-0.26		-0.36	0.83	0.79	0.88	0.55	-0.43	-0.57	-0.57	-0.45	0.61	0.67
Income Tax Expense	0.11	0.22	0.14	0.14	0.14	0.12	0.15	0.14	0.14	0.14	0.12	-0.18	-0.36		0.12	0.13	-0.57	0.1	-0.06	-0.18	-0.18	0.95	0.11	0.06
Selling General Administrative	0.86	0.75	0.99	0.99	0.99	0.96	0.92	0.95	0.98	0.99	0.95	-0.38	0.83	0.12		0.96	0.59	0.77	-0.61	-0.59	-0.59	0.0	0.77	0.79
Research Development	0.93	0.79	0.98	0.98	0.99	0.92	0.88	0.93	0.99	0.98	0.9	-0.35	0.79	0.13	0.96		0.6	0.74	-0.63	-0.55	-0.55	0.03	0.85	0.9
Net Income From Continuing Ops	0.6	0.43	0.6	0.6	0.59	0.65	0.61	0.64	0.6	0.57	0.65	-0.16	0.88	-0.57	0.59	0.6		0.36	-0.35	-0.26	-0.26	-0.56	0.59	0.62
Non Recurring	0.56	0.47	0.75	0.76	0.76	0.67	0.67	0.67	0.74	0.78	0.64	-0.56	0.55	0.1	0.77	0.74	0.36		-0.66	-0.39	-0.39	0.0	0.59	0.5
Non Operating Income Net Other	-0.62	-0.47	-0.63	-0.63	-0.63	-0.55	-0.56	-0.6	-0.62	-0.64	-0.48	0.76	-0.43	-0.06	-0.61	-0.63	-0.35	-0.66		0.02	0.02	-0.02	-0.76	-0.44
Selling And Marketing Expenses	-0.34	-0.58	-0.59	-0.59	-0.57	-0.68	-0.65	-0.59	-0.6	-0.55	-0.7	0.05	-0.57	-0.18	-0.59	-0.55	-0.26	-0.39	0.02		1.0	-0.07	-0.35	-0.52
Minority Interest	-0.34	-0.58	-0.59	-0.59	-0.57	-0.68	-0.65	-0.59	-0.6	-0.55	-0.7	0.05	-0.57	-0.18	-0.59	-0.55	-0.26	-0.39	0.02	1.0		-0.07	-0.35	-0.52
Tax Provision	0.04	0.18	0.02	0.01	0.02	0.0	0.04	0.04	0.03	0.01	0.0	-0.17	-0.45	0.95	0.0	0.03	-0.56	0.0	-0.02	-0.07	-0.07		0.12	0.04
Interest Income	0.81	0.73	0.81	0.8	0.82	0.75	0.7	0.77	0.83	0.8	0.71	-0.46	0.61	0.11	0.77	0.85	0.59	0.59	-0.76	-0.35	-0.35	0.12		0.85
Reconciled Depreciation	0.86	0.86	0.84	0.82	0.85	0.76	0.68	0.77	0.87	0.83	0.75	-0.11	0.67	0.06	0.79	0.9	0.62	0.5	-0.44	-0.52	-0.52	0.04	0.85

Click cells to compare fundamentals

Stryker Account Relationship Matchups

Stryker income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	287M	315M	337M	158M	356M	373.8M
Total Revenue	14.9B	14.4B	17.1B	18.4B	20.5B	21.5B
Gross Profit	9.7B	9.1B	11.0B	11.6B	13.1B	13.7B
Operating Income	2.7B	2.2B	2.6B	2.8B	3.9B	4.1B
Ebit	2.7B	2.2B	2.6B	2.8B	3.9B	4.1B
Ebitda	3.9B	3.1B	3.8B	4.2B	5.0B	5.2B
Cost Of Revenue	5.2B	5.3B	6.1B	6.9B	7.4B	7.8B
Income Before Tax	2.6B	2.0B	2.3B	2.7B	3.7B	3.9B
Net Income	2.1B	1.6B	2.0B	2.4B	3.2B	3.3B
Income Tax Expense	479M	355M	287M	325M	508M	533.4M
Research Development	971M	984M	1.2B	1.5B	1.4B	1.5B
Tax Provision	479M	355M	287M	325M	508M	289.7M
Interest Income	125M	213M	269M	243M	279.5M	192.8M

Stryker Investors Sentiment

The influence of Stryker's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Stryker. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to Stryker's public news can be used to forecast risks associated with an investment in Stryker. The trend in average sentiment can be used to explain how an investor holding Stryker can time the market purely based on public headlines and social activities around Stryker. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Stryker's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Stryker's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Stryker's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Stryker.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Stryker in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Stryker's short interest history, or implied volatility extrapolated from Stryker options trading.

Currently Active Assets on Macroaxis

GOOG	Alphabet Inc Class C
DD	Dupont De Nemours
C	Citigroup
CRM	Salesforce
GM	General Motors

When determining whether Stryker is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stryker Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:

How To Invest In Stryker

Details

Is Stryker Stock a good investment?

Details

What is Stryker's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Stryker Valuation and Stryker Correlation analysis.

For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.

You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Stryker Stock analysis

When running Stryker's price analysis, check to measure Stryker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stryker is operating at the current time. Most of Stryker's value examination focuses on studying past and present price action to predict the probability of Stryker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stryker's price. Additionally, you may evaluate how the addition of Stryker to your portfolios can decrease your overall portfolio volatility.

	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine

Is Stryker's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

1.027

Dividend Share

3.05

Earnings Share

8.26

Revenue Per Share

53.999

Quarterly Revenue Growth

0.118

The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Stryker Income Statement Research

Stryker income statement Correlations

Stryker Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Stryker income statement Accounts

Stryker Investors Sentiment

Currently Active Assets on Macroaxis

Complementary Tools for Stryker Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Total Revenue
Other Operating Expenses	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Other Operating Expenses	+ 1.0	Gross Profit
Cost Of Revenue	+ 1.0	Other Operating Expenses
Total Operating Expenses	+ 1.0	Other Operating Expenses

Interest Income	- 0.76	Non Operating Income Net Other
Minority Interest	- 0.7	Income Before Tax
Selling And Marketing Expenses	- 0.7	Income Before Tax
Minority Interest	- 0.68	Operating Income
Selling And Marketing Expenses	- 0.68	Operating Income
Non Operating Income Net Other	- 0.66	Non Recurring